NORMAL SITUATION

M.S. PHARMA

Export PDF

Financial year 2022 · closed on 31/12/2022

Net result

227,3 k €

+77.6% YoY

Revenue

998,1 k €

-16.7% YoY

Equity

2,2 M €

+11.6% YoY

Company — Normal situation.

What does M.S. PHARMA do?

M.S. PHARMA is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0476.749.852

Legal form

Private company with limited liability

Contributed capital

6 200,00 €

Latest accounts

31/12/2022

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	998,1 k €	-16.7%	1,2 M €	+3.0%	1,2 M €	+9.2%	1,1 M €	+1.1%	1,1 M €	-2.3%	1,1 M €	+0.9%	1,1 M €	-8.5%	1,2 M €	-2.4%	1,2 M €	-29.5%	1,7 M €	-7.8%	1,8 M €	-2.1%	1,9 M €	+2.3%	1,8 M €		–		–		–		–
EBITDA	359,2 k €	+94.9%	184,3 k €	+7.3%	171,7 k €	+39.2%	123,3 k €	+0.6%	122,5 k €	+93.3%	63,4 k €	-45.9%	117,1 k €	+40.1%	83,6 k €	-40.1%	139,5 k €	-79.6%	683,2 k €	+186%	238,6 k €	+31.0%	182 k €	+0.6%	181 k €	-10.0%	201 k €	+4.4%	192,7 k €	+22.0%	158 k €	-18.6%	193,9 k €
Operating result	357 k €	+94.2%	183,9 k €	+7.4%	171,3 k €	+39.4%	122,9 k €	+0.7%	122 k €	+95.8%	62,3 k €	-44.2%	111,8 k €	+46.7%	76,2 k €	-42.1%	131,6 k €	-80.5%	675,7 k €	+201%	224,4 k €	+92.4%	116,6 k €	+10.1%	105,9 k €	-17.6%	128,6 k €	+7.1%	120,1 k €	+48.4%	80,9 k €	-24.7%	107,6 k €
Net result	227,3 k €	+77.6%	128 k €	+12.3%	114 k €	+33.1%	85,6 k €	-5.6%	90,7 k €	+116%	42 k €	-48.3%	81,2 k €	+19.2%	68,1 k €	-33.0%	101,7 k €	-77.5%	451,8 k €	+185%	158,4 k €	+121%	71,6 k €	-0.6%	72,1 k €	-18.0%	88 k €	+16.4%	75,6 k €	+47.7%	51,2 k €	-11.8%	58,1 k €
Balance sheet
Equity	2,2 M €	+11.6%	2 M €	+7.0%	1,8 M €	+6.6%	1,7 M €	+5.2%	1,6 M €	+5.9%	1,5 M €	+2.8%	1,5 M €	+5.7%	1,4 M €	+5.0%	1,4 M €	+4.8%	1,3 M €	+53.6%	842,5 k €	+23.1%	684,2 k €	+11.7%	612,5 k €	+13.3%	540,4 k €	+19.4%	452,5 k €	+20.1%	376,9 k €	+15.7%	325,7 k €
Total assets	2,3 M €	+14.7%	2 M €	+5.1%	1,9 M €	+5.8%	1,8 M €	+6.5%	1,7 M €	+7.2%	1,6 M €	+1.1%	1,6 M €	+7.3%	1,5 M €	-3.3%	1,5 M €	-3.3%	1,6 M €	+69.1%	930,6 k €	+20.7%	771 k €	-6.0%	820,3 k €	+0.6%	815,7 k €	-0.4%	819 k €	+7.3%	763,6 k €	+1.9%	749,4 k €
Cash	1,2 M €	+139%	507,4 k €	-61.5%	1,3 M €	+7.1%	1,2 M €	+6.9%	1,2 M €	+6.1%	1,1 M €	+2.8%	1,1 M €	-4.9%	1,1 M €	-3.8%	1,2 M €	+0.2%	1,2 M €	+164%	436,4 k €	+117%	200,8 k €	-6.9%	215,7 k €	+49.6%	144,2 k €	+123%	64,6 k €	-65.0%	184,5 k €	+86.7%	98,8 k €
Debts	130,1 k €	+107%	62,8 k €	-31.8%	92 k €	-8.0%	100 k €	+35.7%	73,7 k €	+47.1%	50,1 k €	-30.3%	71,9 k €	+59.7%	45 k €	-72.4%	163,3 k €	-40.9%	276,5 k €	+242%	80,8 k €	+1.6%	79,5 k €	-59.9%	198,3 k €	-24.6%	263,1 k €	-23.0%	341,7 k €	-9.0%	375,5 k €	-9.6%	415,4 k €
Other
Workforce	–		–		–		–		–		–		1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+11.1%	0,9 ETP	-10.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+25.0%	0,8 ETP

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 2 ended

Active mandates

MONIQUE JOURET

Director · since 01 janvier 2002

Active

Ended mandates

MONIQUE JOURET

Manager · since 01 janvier 2002

Ended

Stéphane GELDOF

Manager · since 01 janvier 2002

Ended

Annual accounts

Full financial information

	2022	2021	2020	2019	2018	2017
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017
Closing of the financial year	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/03/2023	04/08/2022	01/09/2021	23/07/2020	31/07/2019	13/08/2018
General meeting	06/02/2023	01/05/2022	03/05/2021	04/05/2020	06/05/2019	07/05/2018
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2022	06/02/2023	22/03/2023	French	PDF
Abridged model	31/12/2021	01/05/2022	04/08/2022	French	PDF
Abridged model	31/12/2020	03/05/2021	01/09/2021	French	PDF
Abridged model	31/12/2019	04/05/2020	23/07/2020	French	PDF
Abridged model	31/12/2018	06/05/2019	31/07/2019	French	PDF
Abridged model	31/12/2017	07/05/2018	13/08/2018	French	PDF
Abridged model	31/12/2016	08/05/2017	11/08/2017	French	PDF
Abridged model	31/12/2015	02/05/2016	29/08/2016	French	PDF
Abridged model	31/12/2014	04/05/2015	23/07/2015	French	PDF
Abridged model	31/12/2013	05/05/2014	07/07/2014	French	PDF
Abridged model	31/12/2012	06/05/2013	27/08/2013	French	PDF
Abridged model	31/12/2011	07/05/2012	31/07/2012	French	PDF
Abridged model	31/12/2010	02/05/2011	17/04/2012	French	PDF
Abridged model	31/12/2009	03/05/2010	30/11/2010	French	PDF
Abridged model	31/12/2008	04/05/2009	02/08/2010	French	PDF
Abridged model	31/12/2007	26/05/2008	23/12/2008	French	PDF
Abridged model	31/12/2006	28/05/2007	27/12/2007	French	PDF
Abridged model	31/12/2005	23/05/2006	07/03/2007	French	PDF
Abridged model	31/12/2004	23/05/2005	19/09/2005	French	PDF
Abridged model	31/12/2003	03/05/2004	29/12/2004	French	PDF
Abridged model	31/12/2002	26/05/2003	25/07/2003	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 2 ended

Active mandates

MONIQUE JOURET

Director · since 01 janvier 2002

Active

Ended mandates

MONIQUE JOURET

Manager · since 01 janvier 2002

Ended

Stéphane GELDOF

Manager · since 01 janvier 2002

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Dissolution18/04/2023
RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
PDF
Registered office09/05/2022
SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2022
Annual accounts 2022227,3 k €↑
2021
Annual accounts 2021128 k €↑
2020
Annual accounts 2020114 k €↑
2019
Annual accounts 201985,6 k €↓
2018
Annual accounts 201890,7 k €↑
2017
Annual accounts 201742 k €↓
2016
Annual accounts 201681,2 k €↑
2015
Annual accounts 201568,1 k €↓
2014
Annual accounts 2014101,7 k €↓
2013
Annual accounts 2013451,8 k €↑
2012
Annual accounts 2012158,4 k €↑
2011
Annual accounts 201171,6 k €↓
2010
Annual accounts 201072,1 k €↓
2009
Annual accounts 200988 k €↑
2008
Annual accounts 200875,6 k €↑
2007
Annual accounts 200751,2 k €↓
2006
Annual accounts 200658,1 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

M.S. PHARMA

Overview

What does M.S. PHARMA do?

Trend over 17 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline